News

Filter News By

Clear Filters

  1. CF Foundation Awards Funding for First-Ever Controlled Clinical Study of Phage Therapy in CF

    March 18, 2020

    The Cystic Fibrosis Foundation awarded up to $5 million to Armata Pharmaceuticals for the first-ever controlled clinical study of phage therapy in CF, reaffirming the Foundation’s commitment to advance innovative solutions to the growing challenge of antibiotic resistance.

  2. Cystic Fibrosis Foundation Supports Development of Non-Porcine Enzyme Therapy

    February 12, 2020

    The Cystic Fibrosis Foundation has entered into an agreement with Synspira Therapeutics Inc. to develop a non-porcine enzyme replacement therapy to offer an alternative to people with cystic fibrosis who cannot digest food properly.

  3. CF Foundation Awards Icagen Up to $11 Million for Nonsense Mutation Research

    May 1, 2018

    Icagen Inc. will focus on drug discovery, screening for compounds that could suppress nonsense mutations, and using computer modeling to identify molecules that are suitable to be developed into drugs.

  4. CF Foundation Awards Up to $25 Million for the Development of a Novel Drug to Reduce Inflammation in CF

    January 30, 2018

    The drug company Corbus Pharmaceuticals will start its next Phase 2 clinical trial to test a potential inflammation-targeting drug in people with cystic fibrosis in the first quarter of 2018.

  5. CFFT Activities Transferred to the CF Foundation

    December 12, 2017

    Over the course of 2018, we will be transferring the activities of Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) to the CF Foundation.

  6. CF Foundation Officially Opens One-of-a-Kind Research Lab

    September 16, 2016

    The lab will use the latest scientific advances –- including stem cell research and gene editing –- to accelerate new treatments for cystic fibrosis.
More Posts

Related Content

Follow Us On